Business Context and Reporting Period
This Form 6-K filing by SciSparc Ltd. covers the month of February 2025, with the report dated February 27, 2025. The filing primarily discloses a private placement of convertible debentures and a related loan agreement with AutoMax Motors Ltd. in connection with a proposed merger.
Key Financial Metrics and Capital Structure
- Convertible Debentures: The Company agreed to sell and issue convertible debentures with an aggregate principal amount of $4.2 million.
- Subscription Amount: The purchase price is 95% of the principal amount.
- Interest Rates: Debentures accrue interest at 8% annually, increasing to 18% upon an Event of Default.
- Maturity: Debentures mature one year from the issuance date.
- Warrants: Investors received warrants exercisable for five years at 130% of the volume-weighted average price prior to closing.
- Loan to AutoMax: SciSparc extended a $2 million loan to AutoMax Motors Ltd. on February 24, 2025.
- Loan Terms: Monthly payments of $50,000 plus 8% annual interest. Remaining interest is forgiven upon consummation of the merger.
Material Changes and Transactions
The filing details a significant capital raise and a strategic loan assignment:
- Debt Financing: On February 25, 2025, the Company entered into Securities Purchase Agreements to raise $4.2 million in convertible debt.
- Deed of Assignment: $2 million of the Subscription Amount was assigned to AutoMax Motors Ltd. to satisfy the initial payment under a new Loan Agreement between SciSparc and AutoMax.
- Guarantees: Subsidiaries Brain Bright Ltd. and Evero Health Ltd. entered into a Global Guaranty Agreement to secure the Company's obligations under the Debentures.
- Registration Rights: A Registration Rights Agreement was executed to allow investors to register the resale of conversion shares and warrant shares.
Outlook, Risks, and Contingencies
- Merger Contingency: The forgiveness of remaining interest on the AutoMax loan is contingent upon the consummation of the merger pursuant to the Agreement and Plan of Merger dated April 10, 2024.
- Conversion Mechanics: Conversion prices are subject to a floor price of 20% of the volume-weighted average price on the day prior to closing, protecting against extreme dilution.
- Default Risk: Interest rates on the debentures double to 18% if an Event of Default occurs and remains uncured.
- Regulatory Status: The securities are exempt from registration under Section 4(a)(2) and Rule 506 of Regulation D, though the Company agreed to file a registration statement for resale.
Investor Verification Checklist
- Verify the status of the proposed merger with AutoMax Motors Ltd. and the likelihood of interest forgiveness.
- Review the specific terms of the "Event of Default" in the Debentures to assess the risk of the interest rate increasing to 18%.
- Confirm the financial health of the guarantor subsidiaries (Brain Bright Ltd. and Evero Health Ltd.).
- Check the current trading volume and price of SciSparc Ordinary Shares to estimate potential dilution from the conversion and warrant exercise prices.
- Review the full Registration Statement and Proxy Statement regarding the AutoMax merger for additional risk factors.